Henry Yin

Select and prior experience include:

Public Companies Transactions; Mergers and Acquisitions; IPOs

• Clients across technology, life sciences, financial services, insurance, consumer, manufacturing, fintech, logistics, media, hospitality, big data, blockchain, cryptocurrency and artificial intelligence (AI) sectors in significant transactions, including fundraisings, IPOs, M&As, follow-on offerings and other capital markets activities
• A consortium of investors, including affiliates of Sequoia, Fosun, SAIF, Alibaba Pictures Group Limited and Tencent, in connection with their acquisition of a NASDAQ-listed film production and distribution company at an implied enterprise value of approximately US$1 billion. 
• A consortium consisting of CITIC Guoan, Golden Brick Silk Road Capital, Sequoia Capital China, Taikang Life Insurance, Ping An Insurance, Sunshine Insurance, New China Capital, Huatai Ruilian, Huasheng Capital and their affiliated entities in a US$9.3 billion acquisition of a NYSE-listed software and cybersecurity company.
• An AI-driven health big data firm and the first biotech unicorn in China in its US$3 billion complex restructuring and cross-border acquisitions and subsequent fundraisings.
• Greater China-based listed and private companies in their proposed and completed private and public offshore acquisitions from strategic and financial sellers.
• The shareholders of a cybersecurity solutions provider, on the sale of the company to IBM.
• A leading digital consumer goods/Amazon aggregator, in its proposed and completed acquisitions and expansion in Asia.
• A leading technology-driven cryptocurrency mining company, in its acquisitions and JVs in the crypto-mining space.
• A consortium led by a leading private equity firm and the chairman, president and chief executive officer of a leading provider of biopharmaceutical products in China, in the proposed US$401.8 million acquisition of acquisition of the biopharmaceutical products provider. 
• Various high growth new economy companies and its founders, significant shareholders in restructurings and exits through M&As, including representing founders of a leading online video content provider in China in connection with the restructuring and sale of a controlling interest in the business to a leading international mass media company.
• China’s top post and telecommunications economy development center, in its US$362 million acquisition of Alcatel-Lucent’s enterprise business through a competitive bidding process.
• The special committee of a Chinese fabless chip company specializing in research and development and production and marketing of multimedia processors for personal computers and mobile phones, in connection with the company’s going private transaction.
• Selling shareholders of a global online retail company, in connection with the pending sale of approximately 25.66% equity interest in the Company to a leading leather products fashion company in China. 
• A major Japanese integrated trading and investment business conglomerate in its US$5.3 billion acquisition, including debt from a U.S.-based grains merchant, from owners including leading hedge funds in the reorganization of the Group's businesses in connection with the carve-out of its energy business to bring the final deal value down to US$2.7 billion at closing and in its US$620 million sale of a stake in commodity management firm to a Japanese banking institution. 
• A NASDAQ-listed provider of digital map content and navigation and location-based solutions in China, in its acquisition of a venture capital-backed startup focusing on location-based mobile technologies in the United States. 
• A Chinese state-owned automobile manufacturer as a strategic bidder in an auction of an automotive components manufacturer in the United States and in its proposed acquisition of an electric vehicle automaker in the United States. 
• A Fortune 500 American manufacturer of industrial tools and household hardware and provider of security products in its US$850 million acquisition of a Hong Kong-based maker of engineered mechanical fasteners.
• A leading global multi-line reinsurance company in its proposed US$3.4 billion unsolicited acquisition of a leading international reinsurance organization. 
• A leading provider of mobile internet software technology and services, in its US$251 million acquisition of controlling stake in a leading provider of mobile internet software. 
• One of the world's largest reinsurers in its US$750 million acquisition of the holding company of a financial services company’s life reinsurance operations in North America. 
• A Japanese multinational conglomerate in proposed transactions involving its multibillion-dollar stake in the world's leading supplier of safe, innovative nuclear technology and transactions with strategic partners. 
• A private equity firm in its $312.3 million acquisition of a 21.7% stake in Singapore-listed International Group from an indirect wholly owned subsidiary of Hong Kong-listed company engaged in the research, development, production and sale of single-use medical devices. 
• An American biopharmaceutical company in connection with the unsolicited proposal made by a global pharmaceutical company and in its subsequent US$6.8 billion acquisition by an Israeli multinational pharmaceutical company. 
• A Japanese producer of tapes, vinyl, LCDs, insulation and other products in the acquisition by its subsidiary, a chemical manufacturer, from an international chemical group. 
• A Mexican conglomerate in its proposed unsolicited acquisition of a company listed on the New York and Mexico stock exchanges, with a market cap in excess of US$1.5 billion.

Pre-IPO Investments; Private Equity and Venture Capital; Family Offices

• An AI-driven health big data firm and the first biotech unicorn in China, in its numerous completed and proposed acquisitions of, investments in and transactions with cutting-edge biotech companies and strategic and financial partners around the globe and its other corporate/commercial matters, including several significant cross-border investments into U.S. and Israel-based companies and other undisclosed targets to build an unprecedented ecosystem of the world’s leading bio, health networking, sequencing and AI technology and application companies. 
• Represented a cross-border mobile payment service provider, in its restructuring and multibillion-dollar valuation Series D investment by top-tier PE investors. 
• A leading online Chinese education group, in each of its equity financing rounds, raising hundreds of millions of U.S. dollars from top-tier investors.
• A Beijing-based venture capital firm in private and public investment transactions, including investment in US$600 million Series D financing of a leading self-driving technology company and investment as the lead investor in Series A financing of a biopharmaceutical startup developing target-specific small molecule drugs to treat cancer metastasis. 
• A leading electric vehicle charging solutions service provider, in its Series D financing. 
• A Hong Kong based edtech company, in its Series C-1 financing and other corporate matters. 
• Multiple education and edtech companies in their financings, acquisitions and strategies, restructurings and expansions, including representing a leading online K-12 intelligent education platform in China, in its (i) US$100 million Series D financing by a consortium of investors, (ii) its US$250 million Series E financing by investors and (iii) other proposed and completed corporate matters. 
• An innovative pre-IPO investment platform and its affiliated funds in various completed and proposed direct and indirect investments into unicorn companies, including Airbnb, SpaceX, Palantir Technologies, Paytm, Snapchat, Magic Leap, Hyperloop, DocuSign, Stripe, Lyft, Pinterest and Plastiq. 
• MindWorks Ventures, a growing venture capital fund, in its various investments, including investment in Lalamove, Xtransfer, abc fintech, Dash, Collov, Feiliu Tech, Panex, Glints, Stayplease, Qupital, Powerfultone, 99.co and other high growth companies. 
• An Asian private equity firm in its proposed and completed investments, including in financing of a software company integrating and streamlining private label product development, sourcing and supply chain operations. 
• Nebula, an Amazon brands aggregator, in its complex equity and debt financings. 
• A leading fund-of-funds platform focusing on venture capital fund and direct investment opportunities in China and Asia in various transactions, including investments in (i) a data processing/marketing company, (ii) an online insurance broker and (iii) a provider of next-generation intelligent data analysis platform and other high growth companies. 
• An operator of a Chinese tea franchise in its Series A financing led by a Chinese internet technology company. 
• An institutional family office, in investments into leading technology companies in various areas, including fintech, software, AI and machine learning, real estate tech, wearable technology, autonomous driving, education/edtech, radar sensors, big data, travel platform and media. 
• Advised a U.S. semiconductor company in its establishment of joint venture and its local commercialization in China. 
• Advised a leading wine rating and e-commerce company, in its establishment of joint venture and its local commercialization in China. 
• Tink Labs, a leading hospitality technology solutions firm best known for its handy smartphones, in connection with its various proposed and completed transactions, including in its US$125 million growth financing round led by a subsidiary of the world's largest technology manufacturer and service provider, in its joint venture and strategic alliance with a consumer electronics company in Japan and in its ongoing strategic and financial transactions. 
• A leading emerging markets private equity fund as the lead investor in a fundraising round by the leading taxi-hailing platform in China. The fundraising raised US$2.5 billion in total. The fundraising round was largest private fund raising in the world at the time. 
• Several family offices and billionaires and other Asia-based billionaires, in various undisclosed transactions. 
• Multiple prominent funds in investments into listed and private education/edtech companies. 
• A private equity company in an investment in the largest and fastest growing less-than-truckload (LTL) operator with a franchise model in China. 
• A leading courier and logistics services provider in China, in connection with its pre-IPO US$600 million financing round (multibillion-dollar valuation) by a consortium of top U.S., European and PRC PE investors. 
• Multiple investors, including a fintech focused fund in various investments into high growth fintech companies. 
• Multiple leading real estate tech, co-working and co-living companies in their financings, acquisitions and strategies, restructurings and proposed and completed change of control transactions. 
• A financial services corporation in connection with its investment in up to an aggregate amount of US$150 million in certain senior secured notes issuable by a Cayman issuer. 
• A private equity company in various completed and proposed investments in and outside of China, including the Series E preferred investment in a leading classified advertisement website in China. 
• A leading comprehensive image and video processing service platform in China, in its co-investment with a China-focused venture capital firm into the Series B financing of a mobile photo and social app developer. 
• A leading real estate investor in various proposed China-related transactions. 
• A private banking company in the formation of an offshore U.S. dollar-denominated investment fund with a major state-owned enterprise and one of the largest asset management companies in China, focusing on investments in China and Asia. 
• Members of a high net worth family in the acquisition of a footwear company, and the footwear company’s acquisition of a children’s clothing business from its parent company.
• A medical device company in the corporate reorganization of its U.S. businesses in connection with the spinoff of its global pharmaceutical and imaging business.